THE UNIVERSITY OF BRITISH COLUMBIA

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine
Respiratory Evaluation Sciences Program

We are an academic research group at the University of British Columbia (Vancouver, Canada) with major interest in epidemiological, health economics, and health outcome studies in asthma and chronic obstructive pulmonary disease (COPD)

We are currently looking for graduate students and postdoctoral fellows! Click here for more information

BACKGROUND

The Respiratory Evaluation Sciences Program (RESP) is a comprehensive epidemiology, health outcomes, and health economics program focused on chronic respiratory diseases (namely asthma and chronic obstructive pulmonary disease [COPD]).

Our group has diverse expertise in using clinical data, real-world 'big' data, and computer simulations (disease modeling) techniques to evaluate the real-world effectiveness of health technologies and their 'value for money' potential. Our research has continuously been supported through multiple grants from CIHR and other agencies.

OUR RESEARCH

See more of our research by following categories:

OUR TEAM

LATEST UPDATES

RIC: R Package for the Relative Impact Characteristic (RIC) Curve


Individualized Framingham Lung Function Decline Predictor


epicR: R Package for Evaluation Platform in COPD (EPIC)

PARTNERS

RESP is hosted within UBC Faculty of Pharmaceutical Sciences. Our partners include UBC Division of Respiratory Medicine, and Centre for Clinical Epidemiology and Evaluation.

Our research has been funded by peer-reviewed grants from multiple institutions, including:

GET IN TOUCH

Respiratory Evaluation Sciences Program

2775 Laurel Street
7th Floor, Gordon and Leslie Diamond Health Care Centre
Vancouver, BC, Canada, V5Z 1M9

Principal Investigator: Mohsen Sadatsafavi

Tel: 604-875-4111 ext 66937
Fax: 604-875-5179
Email: msafavi@mail.ubc.ca

828 West 10th Avenue
7th Floor, Research Pavillion
Vancouver, BC, Canada, V5Z 1M9

Emergency Procedures   |   Terms of Use   |   UBC Copyright   |   Accessibility